11 hrs ago
How Angelina Jolie Changed Things For People With BRCA Mutations
"I can tell my children that they don't need to fear they will lose me to breast cancer," said actress Angelina Jolie last May when she announced that she underwent a preventive double mastectomy .
16 hrs ago
Bio IT World
GeneDx Seeks Invalidation of Myriad's BRCA Patents
GeneDx, a commercial genetic diagnostics lab located in Gaithersburg, Maryland, this week filed eleven petitions to invalidate patent claims held by Myriad Genetics, adding another new thread to the increasingly complicated web of litigation surrounding Myriad.
Mon Aug 18, 2014
Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc.,...
These IPR petitions aim to nullify eleven patents owned, co-owned, or licensed by Myriad Genetics, Inc. These patents have been asserted against GeneDx in patent infringement litigation initiated in the United States District Court for the District of The patents at issue all deal with three genes involved in the diagnosis of cancer - two of the ... (more)
Fri Aug 15, 2014
Credit Suisse Reiterates "Neutral" Rating for Myriad Genetics
's stock had its "neutral" rating reaffirmed by equities researchers at Credit Suisse in a research report issued on Friday.
Wed Aug 13, 2014
Myriad Genetics Inc - 10-K - Management's Discussion and Analysis of...
We are a leading molecular diagnostic company dedicated to making a difference in patients' lives through the discovery and commercialization of novel, transformative tests across major diseases.
Salt Lake Tribune
Myriad's profits slip but revenues gain ground
The molecular-diagnostic company, which discovers and commercializes tests assessing a person's risk of developing a disease, had a net quarterly income of $37.1 million in the quarter ending June 30, down from $44.1 million a year earlier.
Stocks On the Move: Kate Spade & Co, Myriad Genetics, Inc., and SeaWorld Entertainment Inc
The rally comes in the wake of encouraging comments from Sterne Agee, which believes the retailer's fundamentals make for a potential buying opportunity.
Morning Movers: SeaWorld Slumps on Big Miss; Ford Gains on Upgrade
The less said about Tuesday the better because there wasn't much to say . Wednesday should provide more topics of conversation.
Tue Aug 12, 2014
Investor's Business Daily
Myriad Genetics Guidance Disappoints, Q4 Edges Views
Gene-tester Myriad Genetics modestly beat fiscal Q4 estimates late Tuesday, but EPS guidance below consensus sent the stock falling 5% in after-hours trading.
Myriad Genetics (MYGN) Releases Quarterly Earnings Results
Myriad Genetics posted its quarterly earnings results on Tuesday. The company reported $0.48 earnings per share for the quarter, beating the analysts' consensus estimate of $0.46 by $0.02, Analyst RN reports.
Examination of Myriad-Mayo Guidance Comments -- International Bioindustry Associations
On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" , to implement a new procedure for determining the subject matter eligibility of claims under 35 U.S.C. 101 in view of the ... (more)
Genetics Lab Refuses To Share Data That Could Save Lives
Myriad Genetics may have lost its singular hold on the market for BRCA1 and BRCA2 testing in May 2013 when the Supreme Court ruled against the patenting of genes , but few outside the science and medical communities are aware that Myriad continues to possess a repository of patient data from BRCA testing that it does not share with researchers ... (more)
Mon Aug 11, 2014
Bloomberg BNA Study Analyzes the Impact of Recent Supreme Court...
Home A Press A Legal & Business A Bloomberg BNA Study Analyzes the Impact of Recent Supreme Court Decisions That Leave Life Sciences Industry under Cloud of Uncertainty Bloomberg BNA Study Analyzes the Impact of Recent Supreme Court Decisions That Leave Life Sciences Industry under Cloud of Uncertainty - Bloomberg BNA and law firm Robins, Kaplan, ... (more)
Myriad Genetics (MYGN) Scheduled to Post Quarterly Earnings on Tuesday
Myriad Genetics is scheduled to issue its Q414 quarterly earnings data on Tuesday, August 12th.
Wed Aug 06, 2014
Examination of Myriad-Mayo Guidance Comments -- ACLU
On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" to implement a new procedure for determining the subject matter eligibility of claims under 35 U.S.C. 101 in view of the ... (more)
Thu Jul 31, 2014
The USPTO Issues Guidelines for Subject Matter Eligibility Analysis:...
On March 4th, 2014, the United States Patent and Trademark Office issued a guidance advising examiners and the public of the factors for determining whether an invention satisfies the provisions of 35 U.S.C. A 101, as applied to patent eligibility in view of the U.S. Supreme Court's decisions in Molecular Pathology v.
The Washington Post
Gene Tests to Match Patients to Therapy to Get FDA Oversight
Commonly used tests to predict disease or match a cancer patient with the drug most likely to work will be more strictly regulated under a U.S. Food and Drug Administration proposal issued today.
FDA To Regulate Thousands Of Cancer, Genetic, And Other Diagnostics
The Food and Drug Administration unveiled plans to regulate thousands of diagnostic tests, including many coming from the exploding field of genetic research, to which it has until now turned a blind eye.
Wed Jul 30, 2014
Myriad Genetics to Announce Financial Results for the Fiscal Fourth...
Myriad Genetics, Inc. today announced that it will issue financial results for the fiscal fourth quarter and full year 2014 as well as provide financial guidance for fiscal year 2015 following the close of market on Tuesday, August 12, 2014.
Wed Jul 23, 2014
North County Public Radio
Biotech firm pulls out of Saranac Lake
The Village of Saranac Lake's plan to grow a cluster of biotechnology companies suffered a setback Monday.